Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repeat Dosing of Liposomal Bupivacaine for Anal Fistula Postop Pain
NCT07081373Recruiting
- Sponsor
- The Sixth Affiliated Hospital of Sun Yat-Sen University
- Start
- Jul 2025
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of liposomal bupivacaine in postoperative pain (2 arms), sponsored by The Sixth Affiliated Hospital of Sun Yat-Sen University. Primary endpoint: Area Under the Curve of the Numerical Rating Scale for pain within 7 Days postoperatively. Started Jul 2025; status: recruiting.
02
Drugs
liposomal bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07081373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07081373.